Latest News and Press Releases
Want to stay updated on the latest news?
-
MOORESTOWN, N.J., March 26, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare®, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, has named Frank...
-
MOORESTOWN, N.J ., March 19, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC). 2020 Women on Boards, the premier global education and advocacy campaign committed to...
-
MOORESTOWN, N.J., March 17, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, enters into an...
-
TRHC will start 2020 with Five New PACE Contracts MOORESTOWN, N.J., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare®, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing...
-
MOORESTOWN, N.J., Nov. 18, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare®, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, will provide...
-
MOORESTOWN, N.J., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare® (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced that...
-
MOORESTOWN, N.J., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare (NASDAQ: TRHC), President and Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD, MBA received...
-
MOORESTOWN, N.J., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc.’s (“TRHC”) (NASDAQ: TRHC) Chief Administrative Officer (CAO) Phillip W. Heath, MS-HSA, received the Minority...
-
MOORESTOWN, N.J., July 18, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, announced today the...
-
MOORESTOWN, N.J., March 16, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC) a healthcare technology company optimizing medication safety by deploying new medication risk...